IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $239,000 | -18.7% | 36,300 | 0.0% | 0.01% | -28.6% |
| Q1 2021 | $294,000 | +149.2% | 36,300 | +98.4% | 0.01% | +75.0% |
| Q4 2020 | $118,000 | +140.8% | 18,300 | +35.6% | 0.00% | +33.3% |
| Q3 2020 | $49,000 | -21.0% | 13,500 | 0.0% | 0.00% | -25.0% |
| Q2 2020 | $62,000 | +34.8% | 13,500 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $46,000 | -9.8% | 13,500 | +35.0% | 0.00% | +33.3% |
| Q4 2019 | $51,000 | +112.5% | 10,000 | 0.0% | 0.00% | +200.0% |
| Q3 2019 | $24,000 | +9.1% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q2 2019 | $22,000 | -18.5% | 10,000 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $27,000 | -85.4% | 10,000 | -61.5% | 0.00% | 0.0% |
| Q2 2017 | $185,000 | +83.2% | 26,000 | 0.0% | 0.00% | – |
| Q1 2017 | $101,000 | +90.6% | 26,000 | 0.0% | 0.00% | – |
| Q4 2016 | $53,000 | -24.3% | 26,000 | 0.0% | 0.00% | – |
| Q3 2016 | $70,000 | -12.5% | 26,000 | 0.0% | 0.00% | – |
| Q2 2016 | $80,000 | – | 26,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 600,000 | $3,870,000 | 2.25% |
| CM Management, LLC | 375,000 | $2,419,000 | 2.24% |
| Consonance Capital Management LP | 3,515,944 | $22,678,000 | 2.12% |
| RA Capital Management | 18,417,458 | $118,793,000 | 1.66% |
| Kercheville Advisors, LLC | 244,421 | $1,564,000 | 0.85% |
| Redmile Group, LLC | 10,528,179 | $67,907,000 | 0.82% |
| Birchview Capital, LP | 190,000 | $1,226,000 | 0.71% |
| QVT Financial LP | 1,375,900 | $8,875,000 | 0.49% |
| Fernwood Investment Management, LLC | 149,340 | $963,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $671,000 | 0.21% |